CHEMO PHARMA LABORATORIES LTD.

Star Source Multi Trade Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with the company's Code of Conduct for Prevention of Insider Trading. The window will be shut for all designated persons, including promoters, directors, key managerial personnel, and connected individuals, starting from July 01, 2026. It will remain closed until two clear trading days after the announcement of the unaudited financial results for the quarter ending June 30, 2026. The company has formally intimated the designated persons about this restriction. The date for the board meeting to approve these financial results will be communicated in due course.

Star Source Multi Trade Ltd has announced its audited standalone financial results for the fourth quarter and year ended March 31, 2026. The results were approved by the Board of Directors in a meeting held on May 29, 2026. Auditors have raised concerns regarding agricultural sales, GST returns variance, balance confirmations, and unsupported loss on fair value change in investments.

Star Source Multi Trade Ltd's board approved the audited standalone financial results for the fourth quarter and year ended March 31, 2026, during its meeting on May 29, 2026. The meeting, held at the company's registered office, commenced at 03:30 PM and concluded at 03:45 PM. SSRV & Associates Chartered Accountants issued an independent auditor's report, noting that the financial results present a true and fair view in accordance with applicable accounting standards. However, the report also highlighted discrepancies between agricultural sales recorded and GST returns, the absence of balance confirmations from various parties, and a lack of adequate explanations for losses on fair value changes in investments.

Star Source Multi Trade Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the Audited Financial Results for the fourth quarter and financial year ended March 31, 2026. The trading window for dealing in the company's shares is closed from April 01, 2026, and will reopen 48 hours after the announcement of the audited financial results.

Star Source Multi Trade Ltd has responded to BSE Limited's request for clarification on the price movement of the company's shares. The company reaffirms its compliance with Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Star Source Multi Trade Ltd has consistently disclosed all price sensitive information and events impacting its operations and performance. The company states that the price movement is market-driven and will continue to inform the stock exchange of any required information under the said regulations.

Star Source Multi Trade Ltd has announced the closure of its trading window for the quarter ending on March 31, 2026. The closure is in accordance with the company's Code of Conduct for Prevention of Insider Trading. The trading window will remain closed for all designated persons, including promoters, directors, key managerial personnel, designated employees, and other connected persons from April 01, 2026, until two clear trading days after the announcement of the audited financial results for the quarter/year ending on March 31, 2026. The designated persons have been informed not to trade in the company's securities during this period. The date of the board meeting for the declaration of financial results will be announced in due course.

Star Source Multi Trade Ltd, formerly known as Chemo Pharma Laboratories Limited, held a Board Meeting on February 12, 2026, at 12:00 PM and concluded at 12:45 PM. The Board approved and considered the Un-Audited Financial Results for the quarter and nine months ended December 31, 2025. The Limited Review Report for the quarter ended on December 31, 2025, was also reviewed and approved. The company's revenue from operations for the nine months ended on December 31, 2025, was 5,256.56 thousand rupees, with a net profit of 6818.00 thousand rupees.

Star Source Multi Trade Ltd. (Formerly known as Chemo Pharma Laboratories Limited) announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company's revenue from operations for the nine-month period stood at ₹ 5,256.56 Thousand, with a net profit before exceptional items and tax of ₹ 6,818.00 Thousand. The board of directors approved the financial results, which were also reviewed by the audit committee.

Star Source Multi Trade Ltd (Formerly known as Chemo Pharma Laboratories Limited) announced its financial results for the quarter and nine months ended December 31, 2025. The company's revenue from operations was 5,256.56 thousand for the nine months ended December 31, 2025. The net profit before extraordinary items and tax was 6,818.00 thousand for the same period. The company is not having any subsidiary company and has only one segment.

Star Source Multi Trade Ltd has informed the BSE that a meeting of the Board of Directors is scheduled on February 12, 2026. The meeting will consider and approve the Un-Audited Financial Results for the quarter and nine months ended December 31, 2025 along with the Limited Review Report. The trading window for dealing in shares of the Company by all designated persons is closed from January 01, 2026 and will re-open on the expiry of 48 hours after the announcement of un-audited Financial Results.